The "microflora Hypothesis" of allergic disease

Advances in Experimental Medicine and Biology

Volumn 635, Issue , 2008, Pages 113-134

  Shreiner, Andrew ^a   Huffnagle, Gary B ^a   Noverr, Mairi C ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; HUMAN; HYPERSENSITIVITY; LIFESTYLE; MICROBIOLOGY; MICROBIOME; MUCOSAL IMMUNITY; REVIEW;

ANIMALS; HUMANS; HYPERSENSITIVITY; IMMUNITY, MUCOSAL; LIFE STYLE; MICROBIOME; MODELS, BIOLOGICAL;

EID: 58149156205     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-09550-9_10     Document Type: Article

References (154)

1. Mannino DM, Homa DM, Pertowski CA et al. Surveillance for asthma-United States, 1960-1995. MMWR CDC Surveill Summ 1998; 47(1):1-27.
2. Beasley R, Crane J, Lai CK et al. Prevalence and etiology of asthma. J Allergy Clin lmmunol 2000; 105(2 Pt 2):S466-472- (Pubitemid 30109009)
3. Burney PG, Luczynska C, Chinn S et al. The European Community Respiratory Health Survey. Eur Respir J 1994: 7(5):954-960. (Pubitemid 24153598)
4. Asher Ml, Keil U, Anderson HR et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8(3):483-491.
5. Noverr MC, Huffnagle GB. The 'microflora hypothesis' of allergic diseases. Clin Exp Allergy 2005; 35(12):1511-1520.
6. Upton MN, McConnachie A, McSharry C et al. Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspring. BMJ 2000; 321 (7253):88-92. (Pubitemid 30438485)
7. Peat JK, Van den Berg RH, Green WF et al, Changing prevalence of asthma in Australian children. BMJ 1994; 308(6944):1591-1596. (Pubitemid 24181866)
8. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12(2):315-335.
9. Worldwide variation in prevalence ofsymptoms of asthma, allergic rhinoconjunctivitis and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351(9111):1225-1232.
10. Gerrard JW; Geddes CA, Reggin PL et al. Serum IgE levels in white and metis communities in Saskatchewan. Ann Allergy 1976; 37(2):91-100.
11. Strachan DP. Hay fever, hygiene and household size. BMJ 1989; 299(6710):1259-1260. (Pubitemid 19280051)
12. Bach JE The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347(12):911-920.
13. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev lmmunol 2001; 1(1):69-75. (Pubitemid 33741977)
14. Umetsu DT, McIntire JJ, Akbari 0 et al. Asthma: an epidemic of dysregulated immunity. Nat lmmunol 2002; 3(8):715-720.
15. Rook GA, Brunet LR. Give us this day our daily germs. Biologist (London) 2002; 49(4):145-149. (Pubitemid 34853420)
16. Rook GA, Brunet LR. Old friends for breakfast. Clin Exp Allergy 2005; 35(7):841-842. (Pubitemid 41032528)
17. Bjorksten B. Effects of intestinal microflora and the environment on the development of asthma and allergy. Springer Semin Immunopathol 2004; 25(3-4):257-270.
18. Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol2004; 12(12):562-8. (Pubitemid 39469905)
19. Noverr MC, Noggle RM, Toews GB et al. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect lmmun 2004; 72(9):4996-5003. (Pubitemid 39223382)
20. Rautava S, Kalliomaki M, Isolauri E. New therapeutic sttategy for combating the increasing burden of allergic disease: Probiotics-A Nutrition, Allergy, Mucosal lnununology and Intestinal Microbiota (NAMI) Research Group report. J Allergy Clin lmmuno12005; 116(1):31-37. (Pubitemid 40909743)
21. Bjorksten B, Naaber P, Sepp E et al. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999; 29(3):342-346. (Pubitemid 29145134)
22. Bjorksten B, Sepp E, julge K et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin lmmunol 2001; 108(4):516-520. (Pubitemid 32978019)
23. He F, Ouwehand AC, Isolauri E et al. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS lnununol Med Microbiol2001; 30(1):43-47. (Pubitemid 32145003)
24. Kalliomaki M, Kirjavainen P, Eerola E et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin lmmuno12001; 107(1):129-134. (Pubitemid 32105256)
25. Kirjavainen PV;Aposrolou E, Arvola T et al. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS lnununol Med Microbiol2001; 32(1):1-7. (Pubitemid 34025068)
26. Ouwehand AC, Isolauri E, He F et al. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin lmmuno12001; 108(1):144-145. (Pubitemid 32662250)
27. Watanabe S, Narisawa Y, Arase S et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin lmmuno12003; 111(3):587-591. (Pubitemid 36337881)
28. Sepp E, Julge K, Mikelsaar M et al. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005; 35(9):1141-1146.
29. Mah Kw; Bjorksten B, Lee BW et al. Distinct pattern of commensal gut microbiota in toddlers with eczema. Int Arch Allergy lmmunol 2006; 140(2):157-163. (Pubitemid 43725810)
30. Bottcher MF, Nordin EK, Sandin A et al. Microflora-associated characteristics in faeces from allergic and non-allergic infants. Clin Exp Allergy 2000; 30(11):1590-1596
31. Woodcock A, Moradi M, Smillie FI et aI. Clostridium difficile, atopy and wheeze during the first year of life. Pediatr Allergy Immuno12002; 13(5):357-360. (Pubitemid 35407861)
32. Murray CS, Tannock GW; Simon MA et aI. Fecal microbiota in sensitized wheezy and nonsensitized nonwheezy children: a nested case-control study. Clin Exp Allergy 2005; 35(6):741-745. (Pubitemid 40961346)
33. Voor T, ]ulge K. Bottcher MF et aI. Atopic sensitization and atopic dermatitis in Estonian and Swedish infants. Clin Exp Allergy 2005; 35(2):153-159. (Pubitemid 40353776)
34. Fanaro S, Chierici R, Guerrini P et al. Intestinal microflora in early infancy: composition and development. Acta Paediatr Supp12003; 91(441):48-55. (Pubitemid 37239252)
35. Tannock GW: Normal Microflora: An Introduction to Microbes Inhabiting the Human Body. London: Chapman and Hall, 1995.
36. Hooper LV. Bacterial contributions to mammalian gut development. Trends Microbiol 2004: 12(3):129-134. (Pubitemid 38314756)
37. Macpherson A], Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4(6):478-485.
38. Xu], Chiang HC, Bjursell MK et aI. Message from a human gut symbiont: sensitivity is a prerequisite for sharing. Trends Microbiol2004; 12(1):21-28. (Pubitemid 38045256)
39. Sullivan A, Edlund C, Nord CEo Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001; 1(2):101-II4. (Pubitemid 33586045)
40. Orrhage K, Nord CEo Bifidobacreria and lactobacilli in human health. Drugs Exp Clin Res 2000; 26(3):95-II1. (Pubitemid 30479604)
41. Sjovall ], Huirfeldt B, Magni L et al. Effect of bera-lactam prodrugs on human intestinal microflora. Scand] Infect Dis Suppl 1986; 49:73-84. (Pubitemid 17224652)
42. Lidbeck A, Nord CEo Lactobacilli and the normal human anaerobic microflora. Clin Infect Dis 1993; 6 (SuppI4):SI81-187.
43. Van der Waaij D. The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Annu Rev Microbiol 1989: 43:69-87.
44. Payne S, Gibson G, Wynne A et al. In vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and Lactobacillus plantarum LPK. Curr Issues Intest Microbiol 2003; 4( I): I -8.
45. Guggenbichler ]P, Kofler J, Allerberger F.The influence of third-generation cephalosporins on the aerobic intestinal flora. Infection 1985; 13 (Suppl 1):S137-139.
46. Mulligan ME, Citron DM, McNamara BT et al. Impact of cefoperazone therapy on fecal flora. Antimicrob Agents Chemother 1982; 22(2):226-230. (Pubitemid 12020112)
47. Samonis G, Gikas A, Anaissie E] et aI. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother 1993; 37(1):51-53. (Pubitemid 23019168)
48. Tannock GW. Analysis of the intestinal microflora using molecular methods. Eur] Clin Nutr 2002; 56 (SuppI4):S44-49. (Pubitemid 36163803)
49. Farooqi IS, Hopkin ]M. Early childhood infection and atopic disorder. Thorax 1998; 53(II):927-932. (Pubitemid 28494330)
50. von Mutius E, Illi S, Hirsch T et aI. Frequency of infections and risk of asthma, atopy and airway hyperresponsiveness in children. Eur Respir ] 1999; 14( 1):4-11. (Pubitemid 29411227)
51. Wjst M, Hoelscher B, Frye C et aI. Early antibiotic treatment and later asthma. Eur] Med Res 2001; 6(6):263-271.
52. McKeever TM, Lewis SA, Smith C et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. ] Allergy Clin Immuno12002; 109(1):43-50. (Pubitemid 34112128)
53. Cullinan P, Harris ], Mills P et al. Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study. Thorax 2004; 59(1):II-15.
54. Ahn KM, Lee MS, Hong S] et al. Fever, use of antibiotics and acute gastroenteritis during infancy as risk factors for the development of asthma in Korean school-age children.] Asthma 2005; 42(9):745-750.
55. Celedon ]C, Fuhlbrigge A, Rifas-Shiman S et al. Antibiotic use in the first year of life and asthma in early childhood. Clin Exp Allergy 2004; 34(7):10II-I016.
56. Illi S, von Mutius E, Lau S et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BM] 2001: 322(7283):390-395.
57. Wickens K, Pearce N, Crane] et al. Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy 1999; 29(6):766-771. (Pubitemid 29268465)
58. Droste ]H, Wieringa MH, Weyler J] et al. Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin Exp Allergy 2000; 30(II):1547-1553.
59. Johnson CC, Ownby DR. Alford SH et al. Antibiotic exposure in early infancy and risk for childhood atopy.] Allergy Clin Immuno12005; 115(6):1218-1224. (Pubitemid 40824592)
60. Cohee C, Cheng S, MacDonald C et aI. Infections, medication use and the prevalence of symptoms of asthma, rhinitis and eczema in childhood.] Epidemiol Community Health 2004; 58(10):852-857. (Pubitemid 39294713)
61. Celedon ]C, Litonjua AA, Ryan L et al. Lack of association between antibiotic use in the first year of life and asthma, allergic rhinitis, or eczema at age 5 years.Am] Respir Crit Care Med 2002; 166(1):72-75. (Pubitemid 34693966)
62. Bremner SA, Carey 1M, DeWilde S et al. Early-life exposure to antibacterials and the subsequent development of hayfever in childhood in the UK: case-control studies using the General Practice Research Database and the Doctors' Independent Network. Clin Exp Allergy 2003; 33(11):1518-1525. (Pubitemid 37421629)
63. Rettger LF, Horton GD. A comparitive study of the intestinal flora of white rats kept on experimental and ordinary mixed diets. Zentralbl Bakteriol1914; 73:362-372.
64. Dubos R, Schaedler R, Stephens M. The effect of antibacterial drugs on the fecal flora of mice. ] Exp Med 1963; 117:231-243.
65. Dubos R. Man Adapting. New Haven: Yale University Press, 1971.
66. Fogarty A, Britton J. Nutritional issues and asthma. Curr Opin Pulm Med 2000; 6(1):86-89.
67. Greene LS. Asthma, oxidant stress and diet. Nutrition 1999; 15(11-12):899-907.
68. Black PN. The prevalence of allergic disease and linoleic acid in the diet. ] Allergy Clin Immuno11999; 103(2 Pt 1):351-352. (Pubitemid 29095844)
69. La Vecchia C, Decarli A, Pagano R. Vegetable consumption and risk of chronic disease. Epidemiology Mar 1998; 9(2):208-210. (Pubitemid 28157622)
70. Weiland SK, von Mutius E, Husing A er al. Intake of trans fatty acids and prevalence of childhood asthma and allergies in Europe. ISAAC Steering Committee. Lancet 1999; 353(9169):2040-2041. (Pubitemid 29271756)
71. Strom K, ]anzon L, Mattisson I et al. Asthma but not smoking-related airflow limitation is associated with a high fat diet in men: results from the population study "Men born in 1914̃ Malmo, Sweden. Monaldi Arch Chest Dis 1996; 51(1):16-21.
72. Morotomi M, Kawai Y, Mutai M. Intestinal microflora in rats: isolation and characterization of strictly anaerobic bacteria requiring long-chain fatty acids. Appl Environ Microbiol 1976; 31(4):475-480.
73. Eyssen H, Parmentier G. Biohydrogenation of sterols and fatty acids by the intestinal microflora. Am] Clin Nutr 1974; 27(11):1329-1340.
74. Eyssen H, Piessens-Denef M, Parmentier G. Role of the cecum in maintaing 5 -steroid- and fatty acid-reducing activity of the rat intestinal microflora.] Nutr 1972; 102(11):1501-1511.
75. Eyssen H. Role of the gut microflora in metabolism of lipids and sterols. Proc Nutr Soc 1973; 32(2):59-63.
76. Martindale S, McNeill G, Devereux G er al. Antioxidant intake in pregnancy in relation to wheeze and eczema in the first two years of life. Am] Respir Crit Care Med 2005; 171(2):121-128. (Pubitemid 40105410)
77. AIm ]S, Swartz ], Lilja G et al. Atopy in children of families with an anthroposophic lifestyle. Lancet 1999; 353(9163):1485-1488.
78. AIm ]S, Swartz J, Bjorksren B et al. An anthroposophic lifestyle and intestinal microflora in infancy. Pediarr Allergy Immuno12002; 13(6):402-411. (Pubitemid 36069951)
79. Chase MW: Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp BioI 1946; 61:257-259.
80. Boyaka PN, Tafaro A, Fischer R et al. Therapeutic manipulation of the immune system: enhancement of innate and adaptive mucosal immunity. CUrt Pharm Des 2003; 9(24):1965-1972. (Pubitemid 37010102)
81. Macaubas C, DeKruyff RH, Umetsu DT. Respiratory tolerance in the protection against asthma. Curr Drug Targets Inflamm Allergy 2003; 2(2):175-186.
82. Mayer L, Shao L. Therapeutic potential of oral tolerance. Nat Rev Immunol 2004; 4(6):407-419. (Pubitemid 38745553)
83. Sudo N, Sawamura S, Tanaka K et al. The requirement of intestinal bacterial flora for the development of an 19E production system fully susceptible to oral tolerance induction. ] Immunol 1997; 159(4):1739-1745. (Pubitemid 127484159)
84. Kiyono H, Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 2004; 4(9):699-710. (Pubitemid 39223076)
85. Eberl G. Inducible lymphoid tissues in the adult gut: recapitulation of a fetal developmental pathway? Nat Rev Immunol 2005; 5(5):413-420. (Pubitemid 40685990)
86. Bauer H, Horowitz RE, Levenson SM et al. The response of the lymphatic tissue to the microbial flora. Studies on germfree mice. Am] Patholl963; 42:471-483.
87. Manolios N, Geczy CL, Schrieber L. High endothelial venule morphology and function are inducible in germ-free mice: a possible role for interferon-gamma. Cell Immuno11988; 117(1):136-151. (Pubitemid 19008742)
88. Hamada H, Hiroi T, Nishiyama Y er al. Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine.] Immuno12002; 168(1):57-64. (Pubitemid 34014102)
89. Fukuyama S, Hiroi T, Yokota Y et al. Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR and NIK signaling pathways but requires the Id2 gene and CD3(-) CD4(+) CD45(+) cells. Immunity 2002; 17(1):31-40. (Pubitemid 34874616)
90. Rescigno M, Urbano M, Valzasina B et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immuno12001; 2(4):361-367. (Pubitemid 33706348)
91. Kerneis S, Bogdanova A, Kraehenbuhl JP et al. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 1997; 277(5328):949-952. (Pubitemid 27366679)
92. Mowat AM. Dendritic cells and immune responses to orally administered antigens. Vaccine 2005; 23(15):1797-1799. (Pubitemid 40331847)
93. Reis e Sousa C. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin lmmunol 2004; 16(1):27-34.
94. Bashir ME, Louie S, Shi HN et al. Toll-like teceptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J lmmunol 2004; In(11):6978-6987. (Pubitemid 38669138)
95. Mellor AL, Baban B, Chandler PR et al. Cutting edge: CpG oligonucleotides induce splenic CDI9+ dendritic cells to acquire potent indoleamine 2.3-dioxygenase-dependent T-cell regulatory functions via IFN Type 1 signaling. J lmmunol2005; 175(9):5601-5605. (Pubitemid 41508038)
96. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+ CD25+ Tecell-mediared suppression by dendritic cells. Science 2003; 299(5609):1033-1036. (Pubitemid 36222922)
97. Csencsits KL, Jutila MA, Pascual DW. Nasal-associated lymphoid tissue: phenotypic and functional evidence for the primary role of peripheral node addressin in naive lymphocyte adhesion to high endothelial venules in a mucosal site. J Immuno11999; 163(3):1382-1389. (Pubitemid 29352758)
98. Spalding DM, Griffin JA. Different pathways ofdifferentiation of pre B-celilines are induced by dendritic cells and T-cells from different lymphoid tissues. Cell 1986; 44(3):507-515.
99. Shikina T, Hiroi T, Iwatani K et al. IgA class switch occurs in the organized nasopharynx- and gutassociated lymphoid tissue, but not in the diffuse lamina propria of airways and gut. J lmmunol 2004; 172(10):6259-6264. (Pubitemid 38621232)
100. Bowman EP, Kuklin NA, Youngman KR et al. The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med 2002; 195(2):269-275. (Pubitemid 34461270)
101. Fagarasan S, Muramatsu M, Suzuki K et al. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 2002; 298(5597):1424-1427. (Pubitemid 35346143)
102. Masopust D, VezysV.Marzo AL et al. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291(5512):2413-2417. (Pubitemid 32231804)
103. Reinhardt RL, Khoruts A, Merica Ret al. Visualizing the generation of memory CD4 T-cells in the whole body. Nature 2001; 410(6824):101-105. (Pubitemid 32225844)
104. Higgins PJ, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J lmmunol 1988; 140(2):440-445. (Pubitemid 18056764)
105. Homann D, Dyrberg T, Petersen Jet al. Insulin in oral immune "tolerance": a one-amino acid change in the B chain makes the difference. J Immuno11999; 163(4):1833-1838.
106. Nagler-Anderson C, Bober LA, Robinson ME et al. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Nat! Acad Sci USA 1986; 83(19):7443-7446. (Pubitemid 16000538)
107. Russo M, Nahori MA, Lefort Jet al. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am J Respir Cell Mol Bioi 2001; 24(5):518-526. (Pubitemid 32442758)
108. Husby S, Mestecky J, Moldoveanu Z et al. Oral tolerance in humans. T-cell but not B-cell tolerance afier antigen feeding. J lmmunol1994; 152(9):4663-4670. (Pubitemid 24134427)
109. Eyles JE, Spiers ID, Williamson ED et al. Tissue distribution of radioactivity following intranasal administration of radioactive microspheres. J Pharm Pharmacol 2001; 53(5):601-607. (Pubitemid 32457810)
110. Pickett TE, Pasetti MF, Galen JE et al. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors. Infect lmmun 2000; 68(1):205-213. (Pubitemid 30016698)
111. Southam DS, Dolovich M, O'Byrne PM et al. Distribution of intranasal instillations in mice: effects of volume, time, body position and anesthesia. Am J Physiol Lung Cell Mol Physiol 2002; 282(4): L833-839. (Pubitemid 34665600)
112. Maeda Y, Noda S, Tanaka K et al. The failure of oral tolerance induction is functionally coupled to the absence ofT-cells in Peyer's patches under germfree conditions. Immunobiology 2001; 204(4):442-457. (Pubitemid 33133937)
113. Sudo N, YuXN, Aiba Y et al. An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice. Clin Exp Allergy 2002; 32(7):1112-1116. (Pubitemid 34779611)
114. Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Nat! Acad Sci USA 1994; 91(14):6688-6692. (Pubitemid 24200727)
115. Mitchison NA. Induction of lmmunological Paralysis in Two Zones of Dosage. Proc R Soc Lond B Bioi Sci 1964; 161:275-292.
116. Barone KS, Jain SL, Michael JG. Effect of in vivo depletion ofCD4+ and CD8+ cells on the induction and maintenance of oral tolerance. Celllmmunol1995; 163(1):19-29.
117. Garside P, Steel M, Liew FY et al. CD4+ but not CD8+ T-cells are required for the induction of oral tolerance. Int Immunol 1995; 7(3):501-504.
118. Yoshida H, Hachimura S. Hirahara K et al. Induction of oral tolerance in splenocyte-reconstituted SCID mice. Clin Immunol Immunoparhol1998; 87(3):282-291. (Pubitemid 28285444)
119. Zhang X, Izikson L. Liu L er al. Activation of CD25(+)CD4(+) regulatory T-cells by oral antigen administration. J Immunol 2001; 167(8):4245-4253. (Pubitemid 32954298)
120. von Boehmer H. Mechanisms of suppression by suppressor T-cells. Nar Immunol 2005, 6(4):338-344.
121. Viney JL, Mowar AM. O'Malley JM er al. Expanding dendriric cells in vivo enhances the induction of oral tolerance. J Immunol 1998;160(12):5815-5825. (Pubitemid 28298039)
122. Hall G, Houghron CG, RahbekJU et al. Suppression of allergen reacrive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-1O production. Vaccine 2003; 21(5-6):549-561. (Pubitemid 36091942)
123. Akbari 0, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-I0 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001, 2(8):725-731. (Pubitemid 32747162)
124. de Heer HJ, Hammad H, Soullie T et al. Essential role oflung plasmacytoid dendritic cells in preventing asrhmatic reactions to harmless inhaled antigen. J Exp Med 2004, 200(1):89-98. (Pubitemid 38924731)
125. Bennett CL, Christie J. Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27(1):20-21. (Pubitemid 32044513)
126. Chatila TA. Blaeser F, Ho N et al. JM2. encoding a fork head-related protein. is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000, 106(12):R75-81. (Pubitemid 32038594)
127. Wildin RS, Ramsdell F. Peake J et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinoparhy syndrome is rhe human equivalent of mouse scurfy. Nat Genet 2001, 27(1):18-20. (Pubitemid 32044512)
128. Bellinghausen I, Klostermann B, Knop J et al. Human CD4+CD25+ T-cells derived from the majority of atopic donors are able to suppress THI and TH2 cytokine production. J Allergy Clin Immunol 2003, 111(4):862-868. (Pubitemid 36470261)
129. Grindebacke H, Wing K, Andersson AC et al. Defective suppression ofTh2 cytokines by CD4CD25 regulatory 'T-cells in birch allergics during birch pollen season. Clin ExpAllergy 2004, 34(9): 1364-1372. (Pubitemid 39233690)
130. Ling EM, Smith T, Nguyen XD et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004, 363(9409):608-615. (Pubitemid 38264178)
131. Calderone RA. ed. Candida and Candidiasis. Washington, DC: ASM Press, 2001:472.
132. Giuliano M, Barza M, Jacobus NY et al. Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemorher 1987, 31(2):202-206. (Pubitemid 17011238)
133. Huang MY. Wang JH. Impact of antibiotic use on fungus colonization in patients hospitalized due to fever. J Microbiol Immunol Infect 2003,36(2):123-128.
134. Maraki S, Margioris AN, Orfanoudaki E et al. Effects of doxycycline. metronidazole and their combination on Candida species colonization of the human oropharynx, intestinal lumen and vagina. J Chernother 2003; 15(4):369-373. (Pubitemid 36904322)
135. Hoberg KA, Cihlar RL, Calderone RA. Inhibitory effect of cerulenin and sodium butyrate on germination of Candida albicans. Antimicrob Agents Chemorher1983, 24(3):401-408. (Pubitemid 13007354)
136. Noverr MC, Huffnagle GB. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun 2004, 72(11):6206-6210. (Pubitemid 39425396)
137. Sjogren J, Maguusson J, Broberg A et al. Antifungal 3-hydroxy fatty acids from Lactobacillus plantarum MiLAB 14. Appl Environ Microbiol2003, 69(12):7554-7557. (Pubitemid 38585417)
138. Maguusson J. Strom K, Roos S er al. Broad and complex antifungal activity among environmental isolates of lactic acid bacteria. FEMS Microbiol Lett 2003, 219(1):129-135. (Pubitemid 36194789)
139. Hogan DA, Vik A, Kolter R. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 2004; 54(5):1212-1223. (Pubitemid 39578266)
140. Bohmig GA. Krieger PM. Saemann MD et al. n-butyrate downregulares rhe stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids. Immunology 1997, 92(2):234-243. (Pubitemid 27428452)
141. Saemann MD, Bohmig GA, Osterreicher CH er al. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition ofIL-12 and up-regulation ofIL-1O production. FASEBJ 2000, 14(15):2380-2382.
142. Cavaglieri CR. Nishiyama A, Fernandes LC et al. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci 2003, 73(13):1683-1690. (Pubitemid 36859872)
143. Andoh A. Bamba T. Sasaki M. Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions. JPEN J Parenter Enteral Nutr 1999, 23(5 Suppl):S70-73.
144. Saemann MD, Bohmig GA, Zlabinger GJ. Short-chain fatty acids: bacterial mediators of a balanced host-microbial relationship in the human gut. Wien Klin Wochenschr 2002; 114(8-9):289-300. (Pubitemid 34546869)
145. Noverr MC, Huffnagle GB. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun 2004; 72(11):6206-10. (Pubitemid 39425396)
146. Noverr MC, Falkowski NR, McDonald RA et al. The development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen and IL-l3. Infect Immun 2005; 73(1):30-38. (Pubitemid 40041094)
147. Hunt JR, Martinelli R, Adams VC et al. Intragastric administration of Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse model. Clin Exp Allergy 2005; 35(5):685-690. (Pubitemid 40769296)
148. + cells with regulatory potential in allergic mice. Eur J Immuno12004; 34(3):631-638. (Pubitemid 39255910)
149. Zuany-Amorim C, Sawicka E, Manlius C er al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002; 8(6):625-629. (Pubitemid 34633442)
150. Kitagaki K, Businga TR, Kline IN. Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice. Clin Exp Immunol 2006; 143(2):249-259.
151. Blumer N, Herz D, Wegmann M et al. Prenatal lipopolysaccharide-exposure prevents allergic sensitization and airway inflammation, but not airway responsiveness in a murine model of experimental asthma. Clin Exp Allergy 2005; 35(3):397-402. (Pubitemid 40516669)
152. Eisenbarth SC, Piggott DA, Huleatt JW er al. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T-helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196(12):1645-1651. (Pubitemid 36026476)
153. Gerhold K, Blumchen K, Bock A et al. Endotoxins prevent murine IgE production, T(H)2 immune responses and development of airway eosinophilia bur not airway hyperreactivity. J Allergy Clin Immuno12002; 110(1):110-116. (Pubitemid 36132736)
154. Racila DM, Kline IN. Perspectives in asthma: molecular use of microbial products in asthma prevention and treatment. J Allergy Clin Immunol 2005; 116(6):1202-1205. (Pubitemid 41740923)